Becton, Dickinson and Company BDX Medical — Other Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Becton, Dickinson and Company’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's medical — other operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's medical — other operating income?
- Becton, Dickinson and Company (BDX) reported medical — other operating income of $4.25M in Q3 2025.
- How has Becton, Dickinson and Company's medical — other operating income changed year-over-year?
- Becton, Dickinson and Company's medical — other operating income increased by 950.0% year-over-year, from -$500K to $4.25M.
- What is the long-term trend for Becton, Dickinson and Company's medical — other operating income?
- Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — other operating income has grown at a 68.3% compound annual growth rate (CAGR), from -$6M to $17M.
- What does medical — other operating income mean?
- Captures miscellaneous operating items not categorized under COGS, SG&A, or R&D, such as gains or losses from asset disposals, litigation settlements, or restructuring charges. It provides a view of non-recurring or peripheral operational impacts.